Psoriasis vulgaris triggered by treatment with mogamulizumab in a patient with cutaneous T-cell lymphoma

J Dtsch Dermatol Ges. 2021 Sep;19(9):1355-1358. doi: 10.1111/ddg.14571. Epub 2021 Aug 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Lymphoma, T-Cell, Cutaneous* / chemically induced
  • Lymphoma, T-Cell, Cutaneous* / diagnosis
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Neoplasm Recurrence, Local
  • Psoriasis* / chemically induced
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • mogamulizumab